BACKGROUND: Respiratory infections are a leading cause of death in Africa, especially among HIV-infected patients. Data on the etiology of fatal respiratory diseases are largely based on autopsy studies. We evaluated causes of pneumonia associated with early mortality among hospitalized HIV-infected patients in Kampala, Uganda. METHODS: Prospective cohort study of HIV-infected patients admitted to Mulago Hospital, Kampala, with at least 2 weeks of cough. Consecutively enrolled patients with negative Ziehl Neelsen sputum smears for acid-fast bacilli underwent bronchoscopy with bronchoalveolar lavage and examination for mycobacteria (smear, solid culture), Pneumocystis jirovecii (Giemsa stain), and fungi (KOH mount, India ink stain, Sabouraud culture). Early mortality was defined as death before the 2-month follow-up visit. RESULTS: Follow-up data were available for 353 (87%) of 407 patients enrolled. Of participants with follow-up data, 112 (32%) died within 2 months. Among patients with early mortality, a diagnosis was confirmed in 74 (66%), including tuberculosis (TB) (56%), cryptococcal pneumonia (1%), Pneumocystis pneumonia (3%), pulmonary Kaposi sarcoma (4%), and pneumonia caused by 2 or more disease processes (3%). CONCLUSIONS: Mortality in HIV-infected TB suspects is high, with TB associated with the largest proportion of deaths. A significant proportion of patients die without a confirmed diagnosis.
BACKGROUND:Respiratory infections are a leading cause of death in Africa, especially among HIV-infectedpatients. Data on the etiology of fatal respiratory diseases are largely based on autopsy studies. We evaluated causes of pneumonia associated with early mortality among hospitalized HIV-infectedpatients in Kampala, Uganda. METHODS: Prospective cohort study of HIV-infectedpatients admitted to Mulago Hospital, Kampala, with at least 2 weeks of cough. Consecutively enrolled patients with negative Ziehl Neelsen sputum smears for acid-fast bacilli underwent bronchoscopy with bronchoalveolar lavage and examination for mycobacteria (smear, solid culture), Pneumocystis jirovecii (Giemsa stain), and fungi (KOH mount, India ink stain, Sabouraud culture). Early mortality was defined as death before the 2-month follow-up visit. RESULTS: Follow-up data were available for 353 (87%) of 407 patients enrolled. Of participants with follow-up data, 112 (32%) died within 2 months. Among patients with early mortality, a diagnosis was confirmed in 74 (66%), including tuberculosis (TB) (56%), cryptococcal pneumonia (1%), Pneumocystis pneumonia (3%), pulmonary Kaposi sarcoma (4%), and pneumonia caused by 2 or more disease processes (3%). CONCLUSIONS: Mortality in HIV-infected TB suspects is high, with TB associated with the largest proportion of deaths. A significant proportion of patients die without a confirmed diagnosis.
Authors: Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg Journal: J Acquir Immune Defic Syndr Date: 2006-09 Impact factor: 3.731
Authors: J Lucian Davis; William Worodria; Harriet Kisembo; John Z Metcalfe; Adithya Cattamanchi; Michael Kawooya; Rachel Kyeyune; Saskia den Boon; Krista Powell; Richard Okello; Samuel Yoo; Laurence Huang Journal: PLoS One Date: 2010-03-26 Impact factor: 3.240
Authors: Neil A Martinson; Alan Karstaedt; W D Francois Venter; Tanvier Omar; Peter King; Tumi Mbengo; Else Marais; James McIntyre; Richard E Chaisson; Martin Hale Journal: AIDS Date: 2007-10-01 Impact factor: 4.177
Authors: R E Hirschtick; J Glassroth; M C Jordan; T C Wilcosky; J M Wallace; P A Kvale; N Markowitz; M J Rosen; B T Mangura; P C Hopewell Journal: N Engl J Med Date: 1995-09-28 Impact factor: 91.245
Authors: Y L Abouya; A Beaumel; S Lucas; A Dago-Akribi; G Coulibaly; M N'Dhatz; J B Konan; A Yapi; K M De Cock Journal: Am Rev Respir Dis Date: 1992-03
Authors: S B Lucas; A Hounnou; C Peacock; A Beaumel; G Djomand; J M N'Gbichi; K Yeboue; M Hondé; M Diomande; C Giordano Journal: AIDS Date: 1993-12 Impact factor: 4.177
Authors: J Batungwanayo; H Taelman; S Lucas; J Bogaerts; D Alard; A Kagame; P Blanche; J Clerinx; P van de Perre; S Allen Journal: Am J Respir Crit Care Med Date: 1994-06 Impact factor: 21.405
Authors: David Muyanja; Robert Kalyesubula; Elizabeth Namukwaya; Emmanuel Othieno; Harriet Mayanja-Kizza Journal: Afr Health Sci Date: 2015-03 Impact factor: 0.927
Authors: Alfred O Andama; Saskia den Boon; David Meya; Adithya Cattamanchi; William Worodria; J Lucian Davis; Nicholas D Walter; Samuel D Yoo; Nelson Kalema; Barbara Haller; Laurence Huang Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731
Authors: Laurence Huang; Adithya Cattamanchi; J Lucian Davis; Saskia den Boon; Joseph Kovacs; Steven Meshnick; Robert F Miller; Peter D Walzer; William Worodria; Henry Masur Journal: Proc Am Thorac Soc Date: 2011-06
Authors: Steve M Taylor; Steven R Meshnick; William Worodria; Alfred Andama; J Lucian Davis; Adithya Cattamanchi; Saskia den Boon; Samuel D Yoo; Carol D Goodman; Laurence Huang Journal: Diagn Microbiol Infect Dis Date: 2011-12-05 Impact factor: 2.803
Authors: Elizabeth J Polvi; Xinliu Li; Teresa R O'Meara; Michelle D Leach; Leah E Cowen Journal: Cell Mol Life Sci Date: 2015-02-21 Impact factor: 9.261
Authors: Sofya Tokman; Christopher F Barnett; Leah G Jarlsberg; Pam R Taub; Saskia den Boon; J Lucian Davis; Adithya Cattamanchi; William Worodria; Alan Maisel; Laurence Huang Journal: Respirology Date: 2014-01-26 Impact factor: 6.424
Authors: Alexander J Stockdale; Joseph Nkuranga; M Estée Török; Brian Faragher; David G Lalloo Journal: Trop Med Int Health Date: 2013-04-17 Impact factor: 2.622